Drugs / Human mAb 216
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00313053 | Sep 2004 → Apr 2008 | acute lymphoblastic leukemia | Clare Twist | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human mAb 216 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00313053 ↗ |
| Action | Deplete | “a human monoclonal antibody that kills B cell acute lymphoblastic leukemia” NCT00313053 ↗ |
| Modality | Monoclonal antibody | “a human monoclonal antibody that kills B cell acute lymphoblastic leukemia” NCT00313053 ↗ |
| Route | Other | “mAb infusion will be given” NCT00313053 ↗ |